
Liangbo Linus Shen, MD, shared phase 2 data showing kamuvudine K8 reduced geographic atrophy growth by 54%.

Liangbo Linus Shen, MD, is a vitreoretinal surgery fellow at Duke University School of Medicine in Durham, North Carolina, where he sees patients at the Duke Eye Center after completing his ophthalmology residency at the University of California, San Francisco.